Article Dans Une Revue Stem Cell Research Année : 2022

Generation of a GPR146 knockout human induced pluripotent stem cell line (ITXi001-A-1)

Résumé

Dyslipidemia is a key modifiable causal risk factor involved in the development of atherosclerotic cardiovascular disease. Recently, the G protein-coupled receptor 146 (GPR146), a member of the G-coupled protein receptors' family, has been shown to be a regulator of plasma cholesterol. Inhibition of hepatic GPR146 in mice displays protective effect against both hypercholesterolemia and atherosclerosis. Here, we characterize a genetically engineered human induced pluripotent stem cell (hiPSC) model invalidated for GPR146 (ITXi001-A-1) using CRISPR-Cas9 editing technology. Differentiation of ITXi001-A-1 towards hepatic fate will provide a suitable model for deciphering the molecular mechanisms sustaining the beneficial metabolic effects of GPR146 inhibition.

Fichier principal
Vignette du fichier
S1873506122000708.pdf (612.46 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)
Licence

Dates et versions

hal-03869113 , version 1 (22-07-2024)

Licence

Identifiants

Citer

Lise Bray, Amandine Caillaud, Aurore Girardeau, Murielle Patitucci, Cédric Le May, et al.. Generation of a GPR146 knockout human induced pluripotent stem cell line (ITXi001-A-1). Stem Cell Research, 2022, 60, pp.102721. ⟨10.1016/j.scr.2022.102721⟩. ⟨hal-03869113⟩
106 Consultations
163 Téléchargements

Altmetric

Partager

  • More